185 related articles for article (PubMed ID: 21212128)
21. Post-transcriptional gene-expression regulation by micro RNA (miRNA) network in renal disease.
Kaucsár T; Rácz Z; Hamar P
Adv Drug Deliv Rev; 2010 Nov; 62(14):1390-401. PubMed ID: 20940025
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of 14q32 microRNA miR-495 reduces lesion formation, intimal hyperplasia and plasma cholesterol levels in experimental restenosis.
Welten SMJ; de Jong RCM; Wezel A; de Vries MR; Boonstra MC; Parma L; Jukema JW; van der Sluis TC; Arens R; Bot I; Agrawal S; Quax PHA; Nossent AY
Atherosclerosis; 2017 Jun; 261():26-36. PubMed ID: 28445809
[TBL] [Abstract][Full Text] [Related]
23. A single anti-microRNA antisense oligodeoxyribonucleotide (AMO) targeting multiple microRNAs offers an improved approach for microRNA interference.
Lu Y; Xiao J; Lin H; Bai Y; Luo X; Wang Z; Yang B
Nucleic Acids Res; 2009 Feb; 37(3):e24. PubMed ID: 19136465
[TBL] [Abstract][Full Text] [Related]
24. MicroRNAs as targets for antisense-based therapeutics.
Stenvang J; Kauppinen S
Expert Opin Biol Ther; 2008 Jan; 8(1):59-81. PubMed ID: 18081537
[TBL] [Abstract][Full Text] [Related]
25. Polysome shift assay for direct measurement of miRNA inhibition by anti-miRNA drugs.
Androsavich JR; Sobczynski DJ; Liu X; Pandya S; Kaimal V; Owen T; Liu K; MacKenna DA; Chau BN
Nucleic Acids Res; 2016 Jan; 44(2):e13. PubMed ID: 26384419
[TBL] [Abstract][Full Text] [Related]
26. Efficient and specific inhibition of plant microRNA function by anti-microRNA oligonucleotides (AMOs) in vitro and in vivo.
He L; Xie M; Huang J; Zhang T; Shi S; Tang T
Plant Cell Rep; 2016 Apr; 35(4):933-45. PubMed ID: 26792284
[TBL] [Abstract][Full Text] [Related]
27. Antagonism of microRNA-122 in mice by systemically administered LNA-antimiR leads to up-regulation of a large set of predicted target mRNAs in the liver.
Elmén J; Lindow M; Silahtaroglu A; Bak M; Christensen M; Lind-Thomsen A; Hedtjärn M; Hansen JB; Hansen HF; Straarup EM; McCullagh K; Kearney P; Kauppinen S
Nucleic Acids Res; 2008 Mar; 36(4):1153-62. PubMed ID: 18158304
[TBL] [Abstract][Full Text] [Related]
28. Novel approaches for gene-specific interference via manipulating actions of microRNAs: examination on the pacemaker channel genes HCN2 and HCN4.
Xiao J; Yang B; Lin H; Lu Y; Luo X; Wang Z
J Cell Physiol; 2007 Aug; 212(2):285-92. PubMed ID: 17516552
[TBL] [Abstract][Full Text] [Related]
29. Non-inhibited miRNAs shape the cellular response to anti-miR.
Androsavich JR; Chau BN
Nucleic Acids Res; 2014 Jun; 42(11):6945-55. PubMed ID: 24810853
[TBL] [Abstract][Full Text] [Related]
30. The role of miR-100-mediated Notch pathway in apoptosis of gastric tumor cells.
Yang G; Gong Y; Wang Q; Wang Y; Zhang X
Cell Signal; 2015 Jun; 27(6):1087-101. PubMed ID: 25703026
[TBL] [Abstract][Full Text] [Related]
31. Robust and specific inhibition of microRNAs in Caenorhabditis elegans.
Kundu ST; Slack FJ
J Biol; 2010; 9(3):20. PubMed ID: 20359318
[TBL] [Abstract][Full Text] [Related]
32. LNA-modified oligonucleotides mediate specific inhibition of microRNA function.
Ørom UA; Kauppinen S; Lund AH
Gene; 2006 May; 372():137-41. PubMed ID: 16503100
[TBL] [Abstract][Full Text] [Related]
33. Misprocessing and functional arrest of microRNAs by miR-Pirate: roles of miR-378 and miR-17.
Deng Z; Yang X; Fang L; Rutnam ZJ; Yang BB
Biochem J; 2013 Mar; 450(2):375-86. PubMed ID: 23210454
[TBL] [Abstract][Full Text] [Related]
34. Potent inhibition of microRNA in vivo without degradation.
Davis S; Propp S; Freier SM; Jones LE; Serra MJ; Kinberger G; Bhat B; Swayze EE; Bennett CF; Esau C
Nucleic Acids Res; 2009 Jan; 37(1):70-7. PubMed ID: 19015151
[TBL] [Abstract][Full Text] [Related]
35. Thyroid hormone may regulate mRNA abundance in liver by acting on microRNAs.
Dong H; Paquette M; Williams A; Zoeller RT; Wade M; Yauk C
PLoS One; 2010 Aug; 5(8):e12136. PubMed ID: 20808432
[TBL] [Abstract][Full Text] [Related]
36. Liver as a target for oligonucleotide therapeutics.
Sehgal A; Vaishnaw A; Fitzgerald K
J Hepatol; 2013 Dec; 59(6):1354-9. PubMed ID: 23770039
[TBL] [Abstract][Full Text] [Related]
37. The systemic administration of an anti-miRNA oligonucleotide encapsulated pH-sensitive liposome results in reduced level of hepatic microRNA-122 in mice.
Hatakeyama H; Murata M; Sato Y; Takahashi M; Minakawa N; Matsuda A; Harashima H
J Control Release; 2014 Jan; 173():43-50. PubMed ID: 24511611
[TBL] [Abstract][Full Text] [Related]
38. microRNA-185 modulates low density lipoprotein receptor expression as a key posttranscriptional regulator.
Jiang H; Zhang J; Du Y; Jia X; Yang F; Si S; Wang L; Hong B
Atherosclerosis; 2015 Dec; 243(2):523-32. PubMed ID: 26523989
[TBL] [Abstract][Full Text] [Related]
39. Effective delivery of anti-miRNA DNA oligonucleotides by functionalized gold nanoparticles.
Kim JH; Yeom JH; Ko JJ; Han MS; Lee K; Na SY; Bae J
J Biotechnol; 2011 Sep; 155(3):287-92. PubMed ID: 21807040
[TBL] [Abstract][Full Text] [Related]
40. MicroRNA 302a is a novel modulator of cholesterol homeostasis and atherosclerosis.
Meiler S; Baumer Y; Toulmin E; Seng K; Boisvert WA
Arterioscler Thromb Vasc Biol; 2015 Feb; 35(2):323-31. PubMed ID: 25524771
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
